Crystals of hydroxynorephedrine derivative

Details Crystals of hydroxynorephedrine derivative Crystals of hydroxynorephedrine derivative

2007-04-24

2007-04-24

Page, Thurman (Department: 1621)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

C514S532000, C514S540000, C514S567000, C514S568000, C514S617000, C560S037000, C560S042000, C562S451000, C564S165000

Reexamination Certificate

active

10489343

ABSTRACT:
The present invention provides ethyl (−)-2-[4-[2-[[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]-2,5-dimethylphenoxy]acetate hydrochloride, crystalline forms thereof and pharmaceutical compositions containing them, which have excellent β3-adrenoceptor stimulating effects, therapeutic effects on pollakiuria or urinary incontinence and storage stabilities and are useful as a medicament.

REFERENCES:
patent: 6538152 (2003-03-01), Tanaka et al.
patent: 1095932 (2001-05-01), None
patent: 2000-212137 (2000-08-01), None
patent: 2000-212138 (2000-08-01), None
patent: 2000-212139 (2000-08-01), None
patent: WO 00/02846 (2000-01-01), None
patent: WO 00/02846 (2000-02-01), None

Affiliated with

Also associated with

Rating

Crystals of hydroxynorephedrine derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Crystals of hydroxynorephedrine derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystals of hydroxynorephedrine derivative will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3797900